NanoEnTek Inc. completed the acquisition of 5% stake in Bio Focus Co., Ltd. Seo, Jung-Gu, KoFC-Tube Pioneer Champ 2011-12 Venture Capital Fund, a fund of HB Investment, Inc., and Lee, Kyung-Jin.
January 19, 2015
Share
NanoEnTek Inc. (KOSDAQ:A039860) agreed to acquire 5% stake in Bio Focus Co., Ltd. from Seo, Jung-Gu, KoFC-Tube Pioneer Champ 2011-12 Venture Capital Fund, a fund of HB Investment, Inc., and Lee, Kyung-Jin for KRW 4.9 billion on September 30, 2014. KoFC-Tube Pioneer Champ 2011-12 Venture Capital Fund, a fund of HB Investment, Inc., sold 0.13 million preferred stocks with voting rights for KRW 3.95 billion, Seo, Jung-Gu sold 0.02 million common stock for KRW 656.7 million and Lee, Kyung-Jin sold stock warrants for KRW 289 million. During the year ended December 31, 2013, Bio Focus Co., Ltd. had total assets of KRW 10.78 billion, sales of KRW 5.21 billion, operating profit of KRW 508.38 million, and net profit of KRW 326.69 million. Bio Focus had total assets of KRW 41.6 billion as of September 30, 2014. The Board of Directors passed a resolution on December 30, 2014. The transaction is expected to close in January 2015 and NanoEnTek Inc. will make payment on same day. With Accounting Corporation acted as evaluation agency.
NanoEnTek Inc. (KOSDAQ:A039860) completed the acquisition of 5% stake in Bio Focus Co., Ltd. Seo, Jung-Gu, KoFC-Tube Pioneer Champ 2011-12 Venture Capital Fund, a fund of HB Investment, Inc., and Lee, Kyung-Jin on January 20, 2015.
NanoenTek,Inc. is a Korea-based company mainly engaged in the manufacturing of point of care testing (POCT) medical equipment and biotechnology research equipment. The Companyâs products consist of Countess, EVE and ADAM, which are cell counting systems; NEON, which are gene delivery systems; JuLI, which are fluorescence microscopes, and chips, which are consumables of cell counting systems. It also provides diagnostic medical equipment, such as FREND systems, which are quantitative immunoassay analyzing devices; ADAM-rWBC, an analytical device for counting the number of residual white blood cells (rWBCs) in leukoreduced blood products, and others. The Company distributes its products within domestic market and to overseas markets.
NanoEnTek Inc. completed the acquisition of 5% stake in Bio Focus Co., Ltd. Seo, Jung-Gu, KoFC-Tube Pioneer Champ 2011-12 Venture Capital Fund, a fund of HB Investment, Inc., and Lee, Kyung-Jin.
NANOENTEK, INC. 
